Trials / Unknown
UnknownNCT04959786
MANS-NRIZ Trial for COVID-19 Treatment : Extension Study
Effect of a Combination of Nitazoxanide, Ribavirin and Ivermectin Plus Zinc Supplement on the Clearance of COVID-19: Extension Study
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This search will focus on patients with COVID 19 infection this study is a prospective cohort study based on the analysis of response in comparative panel between two arm Nitazoxanide, Ribavirin and Ivermectin plus Zinc arm and other arm without any intervention as regards the safety and efficacy and cost effective result. Two years duration of the project would be enough to cover the stages of the work as shown below in the time plan. Initial stage of collecting materials and patients' clinical data, each patient will undergoes strict follow up period to reveal the clinical, laboratory and radiological response. The procedures are to be approved by the institutional ethical committee.
Detailed description
This search will focus on patients with COVID 19 infection this study is a prospective cohort study based on the analysis of response in comparative panel between two arm Nitazoxanide, Ribavirin and Ivermectin plus Zinc arm and other arm without any intervention as regards the safety and efficacy and cost effective result. Two years duration of the project would be enough to cover the stages of the work as shown below in the time plan. Initial stage of collecting materials and patients' clinical data, each patient will undergoes strict follow up period to reveal the clinical, laboratory and radiological response. The procedures are to be approved by the institutional ethical committee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ivermectin,ribavirin ,nitazoxanide and zinc | oral intake of the 3 drugs ivermectin ,ribavirin and nitazoxanide plus zinc |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2022-11-01
- Completion
- 2022-12-01
- First posted
- 2021-07-13
- Last updated
- 2021-07-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04959786. Inclusion in this directory is not an endorsement.